PFM Health Sciences, LP - ENDOLOGIX INC ownership

Quarter-by-quarter ownership
PFM Health Sciences, LP ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q3 2018$14,150,000
-66.9%
7,408,585
-1.8%
0.21%
-69.0%
Q2 2018$42,689,000
+30.3%
7,542,158
-2.6%
0.67%
+0.5%
Q1 2018$32,753,000
-18.5%
7,742,929
+3.1%
0.66%
-30.2%
Q4 2017$40,178,000
+35.3%
7,509,909
+12.8%
0.95%
+63.2%
Q3 2017$29,699,000
+9.1%
6,658,983
+18.9%
0.58%
-20.3%
Q2 2017$27,213,000
+83.9%
5,599,466
+174.0%
0.73%
+97.6%
Q1 2017$14,797,000
+135.9%
2,043,786
+86.4%
0.37%
+109.6%
Q4 2016$6,272,000
-8.5%
1,096,506
+104.7%
0.18%
-11.9%
Q3 2016$6,857,000
-64.7%
535,695
-65.6%
0.20%
-65.7%
Q2 2016$19,424,0001,558,9420.59%
Other shareholders
ENDOLOGIX INC shareholders Q3 2023
NameSharesValueWeighting ↓
Tamarack Capital Management, LLC 4,050,000$49,653,0005.91%
Essex Woodlands Management, Inc. 1,257,468$21,220,0003.88%
PURA VIDA INVESTMENTS, LLC 205,100$2,515,0001.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,347,113$28,776,0001.11%
First Light Asset Management, LLC 180,963$2,219,0001.10%
ArrowMark Colorado Holdings LLC 2,889,546$35,426,0000.97%
PALISADE CAPITAL MANAGEMENT, LP 2,149,949$26,358,0000.78%
Iguana Healthcare Management, LLC 150,000$1,839,0000.72%
CADIAN CAPITAL MANAGEMENT, LP 1,492,443$18,297,0000.66%
WASHINGTON CAPITAL MANAGEMENT, INC 85,882$1,053,0000.66%
View complete list of ENDOLOGIX INC shareholders